Matteo Zignol

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi request reprint Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data
    Matteo Zignol
    Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland Electronic address
    Drug Resist Updat 16:108-15. 2013
  2. pmc Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006
    Pushpa Malla
    National Tuberculosis Centre, Ministry of Health and Population, Kathmandu, Nepal
    PLoS ONE 4:e8313. 2009
  3. pmc Multidrug-resistant tuberculosis, Somalia, 2010-2011
    Ireneaus Sindani
    World Health Organization, Nairobi, Kenya
    Emerg Infect Dis 19:478-80. 2013
  4. pmc Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010
    Matteo Zignol
    Stop TB Department, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Bull World Health Organ 90:111-119D. 2012
  5. pmc Implementation of a national anti-tuberculosis drug resistance survey in Tanzania
    Timothy M Chonde
    1National Tuberculosis and Leprosy Control Program, Ministry of Health and Social Welfare, Dar es Salaam, Tanzania
    BMC Public Health 8:427. 2008
  6. ncbi request reprint Global incidence of multidrug-resistant tuberculosis
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva 1211, Switzerland
    J Infect Dis 194:479-85. 2006
  7. ncbi request reprint Patients with previously treated tuberculosis no longer neglected
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva, CH 1211, Switzerland
    Clin Infect Dis 44:61-4. 2007
  8. pmc Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 52:901-6. 2011
  9. ncbi request reprint Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
    Abigail Wright
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 373:1861-73. 2009
  10. pmc Multidrug-resistant tuberculosis in children: evidence from global surveillance
    Matteo Zignol
    World Health Organization, Geneva, Switzerland
    Eur Respir J 42:701-7. 2013

Collaborators

Detail Information

Publications19

  1. ncbi request reprint Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data
    Matteo Zignol
    Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland Electronic address
    Drug Resist Updat 16:108-15. 2013
    ..Surveillance of drug resistance has been strengthened in the WHO European Region, which has the highest proportions of MDR-TB and XDR-TB ever reported globally. More complete data are needed particularly from the Russian Federation. ..
  2. pmc Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006
    Pushpa Malla
    National Tuberculosis Centre, Ministry of Health and Population, Kathmandu, Nepal
    PLoS ONE 4:e8313. 2009
    ..The aim of this study was to describe treatment outcomes for multi-drug resistant tuberculosis (MDR-TB) outpatients on a standardized regimen in Nepal...
  3. pmc Multidrug-resistant tuberculosis, Somalia, 2010-2011
    Ireneaus Sindani
    World Health Organization, Nairobi, Kenya
    Emerg Infect Dis 19:478-80. 2013
    ..8% of patients with new and previously treated TB, respectively. These levels of drug resistance are among the highest ever documented in Africa and the Middle East. This finding presents a serious challenge for TB control in Somalia...
  4. pmc Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010
    Matteo Zignol
    Stop TB Department, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Bull World Health Organ 90:111-119D. 2012
    ..To present a global update of drug-resistant tuberculosis (TB) and explore trends in 1994-2010...
  5. pmc Implementation of a national anti-tuberculosis drug resistance survey in Tanzania
    Timothy M Chonde
    1National Tuberculosis and Leprosy Control Program, Ministry of Health and Social Welfare, Dar es Salaam, Tanzania
    BMC Public Health 8:427. 2008
    ..The current manuscript describes the implementation of the first national drug resistance survey in Tanzania...
  6. ncbi request reprint Global incidence of multidrug-resistant tuberculosis
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva 1211, Switzerland
    J Infect Dis 194:479-85. 2006
    ....
  7. ncbi request reprint Patients with previously treated tuberculosis no longer neglected
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva, CH 1211, Switzerland
    Clin Infect Dis 44:61-4. 2007
    ..Previously treated patients are difficult to re-treat and represent an important source of disease transmission, as well as a serious threat to TB control worldwide, because of their higher rate of drug resistance...
  8. pmc Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 52:901-6. 2011
    ..Routine surveillance linked to patient care, which represents the best approach to monitor drug resistance, now has the possibility of becoming a reality even in resource-limited countries...
  9. ncbi request reprint Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
    Abigail Wright
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 373:1861-73. 2009
    ..The Global Project on Anti-Tuberculosis Drug Resistance has been gathering data since 1994. This study provides the latest data on the extent of drug resistance worldwide...
  10. pmc Multidrug-resistant tuberculosis in children: evidence from global surveillance
    Matteo Zignol
    World Health Organization, Geneva, Switzerland
    Eur Respir J 42:701-7. 2013
    ..Of particular concern is the association found between age <15 years and MDR-TB in southern African countries with high HIV prevalence...
  11. ncbi request reprint Multidrug-resistant tuberculosis around the world: what progress has been made?
    Dennis Falzon
    Global TB Programme, World Health Organization, Geneva, Switzerland
    Eur Respir J 45:150-60. 2015
    ..Although progress has been noted in the expansion of MDR-TB care, urgent efforts are required in order to provide wider access to diagnosis and treatment in most countries with the highest burden of MDR-TB. ..
  12. ncbi request reprint Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data
    Dennis Falzon
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Lancet Infect Dis 13:690-7. 2013
    ..We assessed the progress towards the 2015 targets achieved by countries accounting for 90% of the estimated MDR-tuberculosis cases in the world in 2011...
  13. ncbi request reprint Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
    Karin Weyer
    Stop TB Dept, World Health Organization, Geneva, Switzerland
    Eur Respir J 42:252-71. 2013
    ....
  14. ncbi request reprint Tb drug resistance: is it really a threat to Africa?
    Paul Nunn
    World Health Organization, Stop TB Department, Avenue Appia 1211 Geneva, Switzerland
    Ethiop Med J 45:399-404. 2007
    ..This paper analyses the threat of TB drug resistance to health and to TB control in Africa, and puts forward measures to diminish this threat...
  15. pmc Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India
    Katherine Floyd
    HIV AIDS, TB and Malaria, World Health Organization, 1211 Geneva 27, Switzerland
    Bull World Health Organ 84:437-45. 2006
    ..To assess the cost and cost-effectiveness of the Public-Private Mix DOTS (PPM-DOTS) strategy for tuberculosis (TB) control in India...
  16. pmc Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda
    Frank G J Cobelens
    KNCV Tuberculosis Foundation, The Hague, The Netherlands
    PLoS Med 5:e150. 2008
  17. pmc Challenges in estimating the total burden of drug-resistant tuberculosis
    Ted Cohen
    Division of Social Medicine and Health Inequalities, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Am J Respir Crit Care Med 177:1302-6. 2008
    ....
  18. pmc Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation study
    Ted Cohen
    Division of Social Medicine and Health Inequalities, Brigham and Women s Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 3:e2363. 2008
    ....
  19. pmc A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis
    Gyanu Lamichhane
    Center for Tuberculosis Research, Department of Medicine, The Johns Hopkins University School of Medicine, 424 North Bond Street, Baltimore, MD 21231 1001, USA
    Proc Natl Acad Sci U S A 100:7213-8. 2003
    ..At subsaturation levels of mutagenesis with a random transposon such as Himar1, this approach permits a statistical prediction of both the proportion and identities of essential genes of sequenced genomes...